A drug in which potential tax credits or grants may provide incentives to assist in the research and development for a condition that affects a very small portion of the general population is known as a/an ______________
a. Orphan drug
b. Expedited drug
c. Investigational new drug
d. Phase 1 drug
a
Rationale: a. A company may receive incentives to encourage research and development of a drug that is meant for a small percentage of the general population.
b. An expedited drug is a drug that moves quickly through the normal phases of human testing when that drug may help in the prevention of a public health crisis.
c. A drug gains the status of investigational new drug when it has completed its preclinical testing phase and is ready for human testing.
d. Phase one refers to a drug testing and approval phase.
You might also like to view...
You are assisting a 29-year-old paraplegic skier who lost control of his sit ski and hit a tree. Even though there are no obvious signs of injury, the patient suddenly starts to feel panicky, and you become concerned about autonomic dysreflexia. Other signs/symptoms that would support this assessment include all of the following except:
a. hypotension. b. altered mental status. c. headache. d. blurred vision.
Your OEC class asks you to describe the term behavior. Which of the following statements would be the correct response?
a. What is acceptable behavior in one community may not be acceptable in another. b. Behavior pertains to how you perform a physical activity only. c. Meditation is the absence of behavior. d. Yelling is never an acceptable behavior.